LSD-Pip: Difference between revisions
CSV import |
CSV import |
||
| Line 31: | Line 31: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
<gallery> | |||
File:LSD-Pip.svg|LSD-Pip | |||
</gallery> | |||
Revision as of 01:08, 20 February 2025
LSD-Pip is a compound from the ergoline family, related to LSD (Lysergic acid diethylamide). It was first synthesized by Alexander Shulgin and reported in his book TiHKAL (Tryptamines I Have Known And Loved).
Chemistry
LSD-Pip, or Lysergic acid 2,4-dimethylazetidide, is a synthetic alkaloid, belonging to the lysergamide class. It is structurally similar to LSD, with the diethylamide group replaced by a 2,4-dimethylazetidide group.
Pharmacology
The pharmacology of LSD-Pip is not well studied. However, it is known to act as a serotonin receptor agonist, like other compounds in the ergoline family. The specific effects and potency of LSD-Pip in humans are not known.
Effects
The effects of LSD-Pip are largely unknown, as it has not been widely studied or used. However, it is likely to produce effects similar to other lysergamides, which can include hallucinations, altered thought processes, and changes in perception of time and space.
Legal Status
The legal status of LSD-Pip varies by country. In many places, it is likely to be considered a controlled substance due to its structural similarity to LSD.
See Also
References
<references />


